May 21, 2021 /

Webinar: ASP0367 Development Program Update (May 19, 2021)

by: Parent Project Muscular Dystrophy

Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program.

5 years ago

Research & Clinical Trial Webinars,

You may also like

Webinar: Capricor Therapeutics — HOPE-3 Community Update

Webinar: Capricor Therapeutics — HOPE-3 Community Update

1 month ago

Research & Clinical Trial Webinars,

Webinar: Avidity Biosciences - EXPLORE44-OLE® Topline and Functional Data Presentation

Webinar: Avidity Biosciences – EXPLORE44-OLE® Topline and Functional Data Presentation

2 months ago

Research & Clinical Trial Webinars,

avidity biosciences,

Becker Muscular Dystrophy Webinar Series – Part 2: Cardiopulmonary Care

Becker Muscular Dystrophy Webinar Series – Part 2: Cardiopulmonary Care

2 months ago

Becker muscular dystrophy,

Webinar: Staying Safe - Avoiding Falls and Recognizing Signs of Fat Embolism Syndrome (FES)

Webinar: Staying Safe – Avoiding Falls and Recognizing Signs of Fat Embolism Syndrome (FES)

3 months ago

Webinar: Neuromuscular Care and Genetic Considerations in Becker

Webinar: Neuromuscular Care and Genetic Considerations in Becker

3 months ago

Becker muscular dystrophy,

neuromuscular care

Webinar: Building Protection - Vaccines and Dystrophinopathy

Webinar: Building Protection – Vaccines and Dystrophinopathy

4 months ago

Webinar: Understanding BiPAP - Why It’s Needed, What Gets in the Way, and How to Increase Compliance

Webinar: Understanding BiPAP – Why It’s Needed, What Gets in the Way, and How to Increase Compliance

5 months ago

Webinar: Capricor - Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy

Webinar: Capricor – Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy

6 months ago

Research & Clinical Trial Webinars,

12 3…28 »

Page 1 of 28

Join Our Mailing List